Investigational New Drug (IND) Application Accepted for EB-105 to Treat Diabetic Macular Edema
[Source: pixabay.com]

Investigational New Drug (IND) Application Accepted for EB-105 to Treat Diabetic Macular Edema

An Investigational New Drug (IND) application is a crucial part of the drug development process. INDs are requests submitted to the U.S. Food and Drug Administration (FDA) that authorize the…

Continue Reading Investigational New Drug (IND) Application Accepted for EB-105 to Treat Diabetic Macular Edema
The Dravet Syndrome Foundation Calls for More Research and Social Awareness on World Epilepsy Day
source: Dravet Foundation Spain

The Dravet Syndrome Foundation Calls for More Research and Social Awareness on World Epilepsy Day

Contributed by Dravet Foundation Spain The group values the progress made but urges the continued implementation of the effectiveness of the drugs Epilepsy unexpectedly and suddenly marks the onset of…

Continue Reading The Dravet Syndrome Foundation Calls for More Research and Social Awareness on World Epilepsy Day
Rare Community Profiles: #RAREis: Advancing Clinical Trial and Patient Equity with the Foundation for Sarcoidosis Research’s Mary McGowan
Fotocitizen / Pixabay

Rare Community Profiles: #RAREis: Advancing Clinical Trial and Patient Equity with the Foundation for Sarcoidosis Research’s Mary McGowan

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: #RAREis: Advancing Clinical Trial and Patient Equity with the Foundation for Sarcoidosis Research’s Mary McGowan